Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

20.93 

-2.51 -10.7%

as of Jan 22 '19

52 Week Range:

20.25 50.98


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes. It also sells food, beds, crates, stairs, strollers, and other pet supplies. The company sells its products through its Internet Website; telephone contact center; and direct mail/print through brochures and postcards. PetMed Express, Inc. was founded in 1996 and is headquartered in Delray Beach, Florida.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Mar '08 Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18
Equity (BVPS) 2.83
3.21
4.21
4.34
3.92
3.09
3.41
3.63
3.95
4.35
5.34
growth rate 13.4% 31.2% 3.1% -9.7% -21.2% 10.4% 6.5% 8.8% 10.1% 22.8%
Earnings BIT 30.41
35.66
40.74
33.28
26.37
27.31
28.40
29.38
32.39
37.48
52.14
growth rate 17.3% 14.3% -18.3% -20.8% 3.6% 4.0% 3.5% 10.2% 15.7% 39.1%
Avg.PE 13.46
16.84
19.38
17.21
15.38
15.67
14.95
19.18
17.43
29.45
21.69
growth rate 25.1% 15.1% -11.2% -10.6% 1.9% -4.6% 28.3% -9.1% 69.0% -26.4%
ROA 29.73
29.57
27.94
19.83
16.88
20.90
23.72
21.65
23.76
23.46
30.11
growth rate -0.5% -5.5% -29.0% -14.9% 23.8% 13.5% -8.7% 9.8% -1.3% 28.4%
ROE 33.13
32.36
30.27
21.53
18.70
23.65
26.78
23.97
25.93
26.98
35.66
growth rate -2.3% -6.5% -28.9% -13.1% 26.5% 13.2% -10.5% 8.2% 4.1% 32.2%
ROIC 33.13
32.36
30.27
21.53
18.70
23.65
26.78
23.97
25.93
26.98
35.66
growth rate -2.3% -6.5% -28.9% -13.1% 26.5% 13.2% -10.5% 8.2% 4.1% 32.2%
Cur. Ratio 7.04
8.81
12.20
10.00
9.33
7.80
9.17
10.84
9.55
4.46
5.81
growth rate 25.1% 38.5% -18.0% -6.7% -16.4% 17.6% 18.2% -11.9% -53.3% 30.3%
Quick Ratio 4.15
4.72
7.79
6.89
6.25
3.90
4.40
7.16
5.56
3.30
4.43
growth rate 13.7% 65.0% -11.6% -9.3% -37.6% 12.8% 62.7% -22.4% -40.7% 34.2%
Leverage 1.10
1.09
1.08
1.10
1.12
1.14
1.12
1.10
1.09
1.21
1.17
growth rate -0.9% -0.9% 1.9% 1.8% 1.8% -1.8% -1.8% -0.9% 11.0% -3.3%
Balance Sheet Mar '08 Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18
Acct.Receivable 1.57
2.90
2.10
2.00
2.80
2.42
2.82
1.93
1.72
1.81
2.29
growth rate 84.7% -27.6% -4.8% 40.1% -13.6% 16.6% -31.6% -10.7% 4.9% 26.8%
Acct.Payable 9.39
9.00
8.09
5.15
5.00
15.22
15.27
growth rate -4.2% -10.1% -36.3% -2.9% 204.2% 0.4%
Cur.Assets 45.22
61.60
86.50
89.60
87.61
68.76
74.21
79.58
67.63
81.79
105.24
growth rate 36.2% 40.4% 3.6% -2.2% -21.5% 7.9% 7.2% -15.0% 20.9% 28.7%
Total Assets 73.45
82.00
104.20
106.30
91.06
73.18
78.38
82.85
90.28
112.81
134.84
growth rate 11.6% 27.1% 2.0% -14.3% -19.6% 7.1% 5.7% 9.0% 25.0% 19.5%
Cash 25.05
30.10
53.10
49.70
46.80
18.16
18.31
35.61
37.64
58.73
77.94
growth rate 20.2% 76.4% -6.4% -5.8% -61.2% 0.8% 94.6% 5.7% 56.0% 32.7%
Inventory 17.91
26.80
29.10
25.10
26.22
31.60
35.73
25.07
25.59
20.23
23.34
growth rate 49.6% 8.6% -13.8% 4.5% 20.5% 13.1% -29.8% 2.1% -20.9% 15.4%
Cur.Liabilities 6.42
7.00
7.10
9.00
9.39
9.00
8.09
7.42
7.08
18.36
18.11
growth rate 9.0% 1.4% 26.8% 4.3% -4.2% -10.1% -8.4% -4.5% 159.1% -1.3%
Liabilities 6.42
7.00
7.30
9.30
9.88
9.17
8.16
7.42
7.08
19.44
19.11
growth rate 9.0% 4.3% 27.4% 6.3% -7.3% -11.0% -9.1% -4.5% 174.5% -1.7%
LT Debt 0.00 0.00 0.00 0.00 0.00 0.00
growth rate
Equity 67.03
75.00
96.90
97.00
81.18
64.01
70.22
75.43
83.19
93.36
115.72
growth rate 11.9% 29.2% 0.1% -16.3% -21.2% 9.7% 7.4% 10.3% 12.2% 24.0%
Common Shares 24.00
23.00
23.00
23.00
21.00
20.00
20.00
20.00
20.00
20.00
20.00
growth rate -4.2% 0.0% 0.0% -8.7% -4.8% 0.0% 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Mar '08 Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18
Capital Expenditures 0.50
3.20
1.00
0.70
0.71
0.63
0.05
0.92
20.13
10.60
0.70
growth rate 540.0% -68.8% -30.0% 0.7% -11.2% -92.8% 1,940.0% 2,092.8% -47.3% -93.4%
Cash Dividends 0.00
0.00
6.80
10.70
10.96
31.97
13.33
13.81
14.68
15.51
17.47
growth rate 57.4% 2.5% 191.6% -58.3% 3.6% 6.4% 5.6% 12.6%
Cash From OA 19.38
15.00
27.70
30.10
20.39
13.29
13.51
32.04
21.05
47.20
37.38
growth rate -22.6% 84.7% 8.7% -32.3% -34.8% 1.6% 137.3% -34.3% 124.2% -20.8%
FCF per Share 0.78
0.48
1.17
1.30
0.54
1.38
0.45
1.24
1.21
0.01
2.42
growth rate -38.5% 143.8% 11.1% -58.5% 155.6% -67.4% 175.6% -2.4% -99.2% 24,100.0%
Sale Purchase of Stock -23.69
-3.87
growth rate 0.0%
FCF 19.00
11.00
27.00
29.00
20.00
13.00
13.00
31.00
1.00
37.00
37.00
growth rate -42.1% 145.5% 7.4% -31.0% -35.0% 0.0% 138.5% -96.8% 3,600.0% 0.0%
Income Statement Mar '08 Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18
Sales 188.34
219.40
238.30
231.60
238.25
227.83
233.39
229.40
234.68
249.18
273.80
growth rate 16.5% 8.6% -2.8% 2.9% -4.4% 2.4% -1.7% 2.3% 6.2% 9.9%
Op.Income 28.00
34.20
40.50
33.00
16.66
17.17
28.22
29.38
32.39
37.48
52.14
growth rate 22.1% 18.4% -18.5% -49.5% 3.0% 64.4% 4.1% 10.2% 15.7% 39.1%
IBT 30.41
35.70
40.70
33.30
26.37
27.31
28.40
27.80
32.57
37.92
53.79
growth rate 17.4% 14.0% -18.2% -20.8% 3.6% 4.0% -2.1% 17.2% 16.5% 41.8%
Net Income 20.02
23.00
26.00
20.90
16.66
17.17
17.97
17.45
20.57
23.82
37.28
growth rate 14.9% 13.0% -19.6% -20.3% 3.0% 4.7% -2.9% 17.8% 15.8% 56.5%
EPS 0.82
0.98
1.14
0.92
0.80
0.86
0.90
0.87
1.02
1.17
1.82
growth rate 19.5% 16.3% -19.3% -13.0% 7.5% 4.7% -3.3% 17.2% 14.7% 55.6%
Gross Profit 74.21
85.30
91.90
84.00
80.17
77.12
77.62
76.27
76.30
79.31
97.81
growth rate 14.9% 7.7% -8.6% -4.6% -3.8% 0.6% -1.7% 0.0% 4.0% 23.3%

Quarterly Statements

Item Name Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Earnings BIT 12.25
11.47
14.00
15.76
13.20
growth rate -6.4% 22.1% 12.5% -16.2%
Balance Sheet Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Acct.Receivable 2.01
1.72
2.29
2.43
1.79
growth rate -14.8% 33.6% 6.1% -26.5%
Acct.Payable 10.38
12.43
15.27
21.18
14.28
growth rate 19.8% 22.9% 38.7% -32.6%
Cur.Assets 94.57
105.59
105.24
123.32
119.13
growth rate 11.7% -0.3% 17.2% -3.4%
Total Assets 124.88
135.59
134.84
152.67
148.07
growth rate 8.6% -0.6% 13.2% -3.0%
Cash 68.44
81.00
77.94
94.56
87.13
growth rate 18.3% -3.8% 21.3% -7.9%
Inventory 23.01
21.91
23.34
25.05
28.62
growth rate -4.8% 6.5% 7.3% 14.3%
Cur.Liabilities 19.26
24.93
18.11
27.96
17.05
growth rate 29.5% -27.4% 54.4% -39.0%
Liabilities 20.56
25.61
19.11
28.79
18.23
growth rate 24.6% -25.4% 50.7% -36.7%
LT Debt
growth rate
Equity 104.31
109.97
115.72
123.87
129.83
growth rate 5.4% 5.2% 7.0% 4.8%
Common Shares 0.02
0.02
0.02
0.02
0.02
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Capital Expenditures 0.31
0.21
0.14
0.31
0.14
growth rate -30.3% -35.1% 120.1% -52.9%
Cash Dividends 4.18
4.07
5.10
5.10
5.65
growth rate -2.6% 25.3% 0.0% 10.8%
Cash From OA 4.41
16.84
2.23
22.03
-1.63
growth rate 282.2% -86.7% 886.3% -100.0%
Sale Purchase of Stock
growth rate
FCF 4.10
16.63
2.10
21.73
-1.78
growth rate 305.6% -87.4% 937.1% -100.0%
Income Statement Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Sales 66.71
60.11
67.32
87.39
71.40
growth rate -9.9% 12.0% 29.8% -18.3%
Op.Income 12.25
11.47
14.00
15.76
13.20
growth rate -6.4% 22.1% 12.5% -16.2%
IBT 12.64
11.92
14.49
16.45
13.89
growth rate -5.7% 21.5% 13.6% -15.6%
Net Income 8.76
9.06
10.18
12.58
10.75
growth rate 3.5% 12.4% 23.6% -14.5%
EPS
growth rate
Gross Profit 23.48
21.94
24.92
29.95
25.26
growth rate -6.5% 13.6% 20.2% -15.7%
R&D
growth rate

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (70.51)

YOY Growth Grade:

D (39.72)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 11.27 10.06 10.06
EPS / Growth 11.8% 2.08 10.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 10.5%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 10.0% 10.8% 10.8%
Future PE 10.06 14.28 14.28
Future EPS 5.40 5.78 5.78
Value Price
MOS %
13.42
-35.9%
20.41
-2.5%
20.41
-2.5%
MOS Price 6.71 10.20 10.20
IRT 6.81 6.66 6.66

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.